"Originally, Oxford intended to donate the rights to manufacture and market the vaccine to any drugmaker who wanted to do so, but after the Gates Foundation urged Oxford to find a large company partner to get its COVID-19 vaccine to market, the university backed off ... An initially not-for-profit licensing agreement was signed ...
"
The university traded what it should have done for the potential future funding by the Gates Foundation.